Encoded Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Encoded Therapeutics's estimated annual revenue is currently $43.8M per year.
- Encoded Therapeutics's estimated revenue per employee is $193,750
- Encoded Therapeutics's total funding is $239.1M.
Employee Data
- Encoded Therapeutics has 226 Employees.
- Encoded Therapeutics grew their employee count by 16% last year.
Encoded Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder, CEO | Reveal Email/Phone |
2 | Co-founder, CSO | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | COO | Reveal Email/Phone |
5 | CTO | Reveal Email/Phone |
6 | VP, Head Intellectual Property | Reveal Email/Phone |
7 | VP MSAT and Manufacturing | Reveal Email/Phone |
8 | VP, Engineering | Reveal Email/Phone |
9 | VP Clinical and Medical Affairs; Head the Medical Office | Reveal Email/Phone |
10 | Head Legal | Reveal Email/Phone |
Encoded Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Encoded Therapeutics?
Encoded Therapeutics Inc. is a biotechnology company advancing precision medicines for a broad range of genetic disorders. Our mission is to unlock new opportunities for viral gene therapy through genomics-driven discovery. We focus on delivering life-changing advances for individuals with genetic disorders not addressable with current approaches. For more information, please visit www.Encoded.com
keywords:N/A
$239.1M
Total Funding
226
Number of Employees
$43.8M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Encoded Therapeutics News
Discovery of unusual dimeric piperazyl cyclopeptides encoded by a ... of humankind's most important and enduring sources of therapeutics.
Precision gene therapy company Encoded Therapeutics announced it has raised $135 million in an oversubscribed Series D round of funding Precision gene therapy company Encoded Therapeutics, Inc. (Encoded) announced it has raised $135 million in an oversubscribed Series D round of funding. And th ...
Encoded Therapeutics, Inc., a South Francisco, Calif.-based precision gene therapy company, raised $135m in Series D financing. The round was led by GV (formerly Google Ventures) with participation from Matrix Capital Management, ARCH Venture Partners, Illumina Ventures, RTW Investments, Boxer ...
SOUTH SAN FRANCISCO, Calif., July 22, 2020 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company, today announced it has raised $135 million in an oversubscribed Series D financing. The company also announced that its lead asset, ETX101, was granted Orphan Drug D ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34.2M | 227 | -22% | $35M |
#2 | $55.7M | 230 | 8% | N/A |
#3 | $37.7M | 243 | -7% | N/A |
#4 | $48.6M | 251 | -4% | $65M |
#5 | $147.3M | 261 | -2% | $192.5M |